Advertisement

Vascular Endothelial Growth Factor: A Key Regulator of Physiologic Angiogenesis

  • Napoleone Ferrara
Part of the Cardiovascular Molecular Morphogenesis book series (CARDMM)

Abstract

The development of a vascular supply is essential not only for organ development and differentiation during embryogenesis but also for wound healing and reproductive functions in the adult (Folkman, 1995). Angiogenesis is also implicated in the pathogenesis of a variety of disorders, including proliferative retinopathies, age-related macular degeneration, tumors, rheumatoid arthritis, and psoriasis (Garner, 1994; Folkman, 1995).

Keywords

Vascular Endothelial Growth Factor Vascular Endothelial Growth Factor Receptor Corpus Luteum Vascular Endothelial Growth Factor mRNA Serum Vascular Endothelial Growth Factor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aboulghar, M. A., Mansour, R. T., Serour, G. I., El Helw, B. A., and Shaarawy, M. 1999. Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascetic fluid of patients with severe ovarian hyperstimulation syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 87:81–85.PubMedCrossRefGoogle Scholar
  2. Agrawal, R., Conway, G., Sladkevicius, P., Tan, S. L., Engmann, L., Payne, N., Bekir, J., Campbell, S., and Jacobs, H. 1998. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries. Fertil. Steril. 70:651–658.CrossRefGoogle Scholar
  3. Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., Nguyen, H., Aiello, L. M., Ferrara, N., and King, G. L. 1994. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331:1480–1487.PubMedCrossRefGoogle Scholar
  4. Aiello, L. P., Pierce, E. A., Foley, E. D., Takagi, H., Chen, H., Riddle, L., Ferrara, N., King, G. L., and Smith, L. E. 1995. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl. Acad. Sci. USA 92:10457–10461.PubMedCrossRefGoogle Scholar
  5. Alon, T., Hemo, I., Itin, A., Pe’er, J., Stone, J., and Keshet, E. 1995. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1:1024–1028.Google Scholar
  6. Bassett, D. L. 1943. The changes in the vascular pattern of the ovary of the albino rat during the estrous cycle. Am. J. Anat. 73:251–259.CrossRefGoogle Scholar
  7. Bates, D. O., and Curry, F. E. 1996. Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels. Am. J. Physiol. 271:H2520–H2528.PubMedGoogle Scholar
  8. Bates, D. O., and Curry, F. E. 1997. Vascular endothelial growth factor increases micro-vascular permeability via a Ca(2+)-dependent pathway. Am. J. Physiol. 273:H687–H694.PubMedGoogle Scholar
  9. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W, and Nagy, A. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435–439.PubMedCrossRefGoogle Scholar
  10. Carmeliet, P., Ng, Y.-S., Nuyens, D., Theilmeier, G., Brusselmans, K., Cornelissen, I., Ehler, E., Kakkar, V. V., Stalmans, I., Mattot, V., Perriard, J.-C., Dewerchin, M., Flameng, W., Nagy, A., Lupu, F., Moons, L., Collen, D., D’Amore, P. A., and Shima, D. T. 1999. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelila growth factor isoforms VEGF164 and VEGF188. Nat. Med. 5:495–502.Google Scholar
  11. Conn, G., Bayne, M. L., Soderman, D. D., Kwok, P. W., Sullivan, K. A., Palisi, T. M., Hope, D. A., and Thomas, K. A. 1990. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 87:2628–2632.PubMedCrossRefGoogle Scholar
  12. Cullinan-Bove, K., and Koos, R. D. 1993. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology 133:829–837.PubMedCrossRefGoogle Scholar
  13. Cunningham, S. A., Waxham, M. N., Arrate, P. M., and Brock, T. A. 1995. Interaction of the Flt-1 tyrosine kinase receptor with the p85 subunit of phosphatidylinositol 3-kinase Mapping of a novel site involved in binding. J. Biol. Chem. 270:20254–20257.PubMedCrossRefGoogle Scholar
  14. D’Ambrogio, G., Fasciani, A., Monti, M., Cattani, R., Genazzani, A. R., and Artini, P. G. 1999. Serum vascular endothelial growth factor levels before starting gonadotropin treatment in women who have developed moderate forms of ovarian hyperstimulation syndrome. Gynecol. Endocrinol. 13:311–315.Google Scholar
  15. Davis-Smyth, T., Chen, H., Park, J., Presta, L. G., and Ferrara, N. 1996. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. EMBO J. 15:49194927.Google Scholar
  16. Davis-Smyth, T., Presta, L. G., and Ferrara, N. 1998. Mapping the charged residues in the second immunoglobulin-like domain of the vascular endothelial growth factor/placenta growth factor receptor Flt-1 required for binding and structural stability. J. Biol. Chem. 273:3216–3222.PubMedCrossRefGoogle Scholar
  17. de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., and Williams, L. T. 1992. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989–991.PubMedCrossRefGoogle Scholar
  18. Dvorak, H. F. 1986. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315:1650–1659.PubMedCrossRefGoogle Scholar
  19. Dvorak, H. F., Brown, L. F., Detmar, M., and Dvorak, A. M. 1995. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146:1029–1039.PubMedGoogle Scholar
  20. Eliceiri, B. P., Paul, R., Schwartzberg, P. L., Hood, J. D., Leng, J., and Cheresh, D. A. 1999. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol. Cell. 4:915–924.Google Scholar
  21. Engel, T., Jewelewicz, R., Dyrenfurth, I., Speroff, L., and Vande Wide, R. L. 1972. Ovarian hyperstimulation syndrome: report of one case with notes on pathogenesis and treatment. Am. J. Obstet. Gynecol. 112:1052–1057.PubMedGoogle Scholar
  22. Enholm, B., Jussila, L., Karkkainen, M., and Alitalo, K. 1998. Vascular endothelial growth factor-C: a growth factor for lymphatic and blood vessel endothelial cells. Trends Cardiovasc. Med. 8:292–296.Google Scholar
  23. Esser, S., Wolburg, K., Wolburg, H., Breier, G., Kurzchalia, T., and Risau, W. 1998. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J. Cell Biol. 140:947–959.PubMedCrossRefGoogle Scholar
  24. Fasciani, A., D’Ambrogio, G., Bocci, G., Monti, M., Genazzani, A. R., and Artini, P. G. 2000. High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata. Mol. Hum. Reprod. 6:50–54.Google Scholar
  25. Ferrara, N. 1999. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int. 56:794–814.PubMedCrossRefGoogle Scholar
  26. Ferrara, N., and Alitalo, K. 1999. Clinical applications of angiogenic growth factors and their inhibitors. Nat. Med. 5:1359–1364.Google Scholar
  27. Ferrara, N., Carver Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K. S., Powell Braxton, L., Hillan, K. J., and Moore, M. W. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439–442.PubMedCrossRefGoogle Scholar
  28. Ferrara, N., Chen, H., Davis-Smyth, T., Gerber, H.-P., Nguyen, T.-N., Peers, D., Chisholm, V., Hillan, K. J., and Schwall, R. H. 1998. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat. Med. 4:336–340.Google Scholar
  29. Ferrara, N., and Davis-Smyth, T. 1997. The biology of vascular endothelial growth factor. Endocr. Rev. 18:4–25.Google Scholar
  30. Ferrara, N., and Henzel, W. J. 1989. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161:851–858.Google Scholar
  31. Finnerty, H., Kelleher, K., Morris, G. E., Bean, K., Merberg, D. M., Kriz, R., Morris, J. C., Sookdeo, H., Turner, K. J., and Wood, C. R. 1993. Molecular cloning of murine FLT and FLT4. Oncogene 8:2293–2298.PubMedGoogle Scholar
  32. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:27–31.Google Scholar
  33. Folkman, J., and Shing, Y. 1992. Angiogenesis. J. Biol. Chem. 267:10931–10934.Google Scholar
  34. Fong, G. H., Rossant, J., Gertsenstein, M., and Breitman, M. L. 1995. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66–70.PubMedCrossRefGoogle Scholar
  35. Fraser, H. M., Dickson, S. E., Lunn, S. F., Wulff, C., Morris, K. D., Carroll, V. A., and Bicknell, R. 2000. Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor. Endocrinology 141:995–1000.PubMedCrossRefGoogle Scholar
  36. Fujisawa, H., and Kitsukawa, T. 1998. Receptors for collapsin/semaphorins. Curr. Opin. Neurobiol. 8:587–592.PubMedCrossRefGoogle Scholar
  37. Galland, F., Karamysheva, A., Mattei, M. G., Rosnet, O., Marchetto, S., and Birnbaum, D. 1992. Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase gene. Genomics 13:475–478.PubMedCrossRefGoogle Scholar
  38. Garner, A. 1994. Vascular diseases. In: Garner, A. and Klintworth, J. K., eds. Pathobiology of Ocular Diseases, 2nd ed. Marcel Dekker, New York, pp. 1625–1710.Google Scholar
  39. Gerber, H. P., Dixit, V., and Ferrara, N. 1998a. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bel-2 and Al in vascular endothelial cells. J. Biol. Chem. 273:13313–13316.CrossRefGoogle Scholar
  40. Gerber, H. P., Hillan, K. J., Ryan, A. M., Kowalski, J., Keller, G.-A., Rangell, L., Wright, B. D., Radtke, F., Aguet, M., and Ferrara, N. 1999a. VEGF is required for growth and survival in neonatal mice. Development 126:1149–1159.Google Scholar
  41. Gerber, H. P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B. A., Dixit, V., and Ferrara, N. 1998b. VEGF regulates endothelial cell survival by the PI3-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem. 273:30366–30343.CrossRefGoogle Scholar
  42. Gerber, H. P., Vu, T. H., Ryan, A. M., Kowalski, J., Werb, Z., and Ferrara, N. 1999b. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5:623–628.Google Scholar
  43. Gille, H., Kowalski, J., Li, B., Moffat, B., Zioncheck, T., Peleltier, N., and Ferrara, N. 2001. Signaling and biological effects mediated by VEGFR-1 and VEGFR-2. A reassessment using novel receptor-specific VEGF mutants. J. Biol. Chem. 276:3222–3230.PubMedCrossRefGoogle Scholar
  44. Gille, H., Kowalski, J., Yu, L., Chen, H., Pisabarro, M. T., Davis-Smyth, T., and Ferrara, N. 2000b. A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits VEGF-dependent PI 3 kinase activation and endothelial cell migration. EMBO J. 19:4064–4073.CrossRefGoogle Scholar
  45. Goede, V., Schmidt, T., Kimmina, S., Kozian, D., and Augustin, H. G. 1998. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab. Invest. 78:1385–1394.Google Scholar
  46. Goldsman, M., Pedram, A., Dominguez, C., Ciuffardi, I., Levin, E., and Asch, R. H. 1995. Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome. Fertil. Steril. 63:268–272.Google Scholar
  47. Goldziher, J. W., and Green, J. A. 1962. The polycistic ovary. I. Clinical and histologic features. J. Clin. Endocrinol. Metab. 22:325–332.Google Scholar
  48. Gospodarowicz, D., and Thakral, K. K. 1978. Production of a corpus luteum angiogenic factor responsible for proliferation of capillaries and neovascularization of the corpus luteum. Proc. Natl. Acad. Sci. USA 75:847–851.PubMedCrossRefGoogle Scholar
  49. Grunstein, J., Masbad, J. J., Hickley, R., Giordano, F., and Johnson, R. S. 2000. Isoforms of vascular endothelial growth factor act in a coordinated fashion to recruit and expand tumor vasculature. Mol. Cell. Biol. 20:7282–7291.Google Scholar
  50. Guerrin, M., Moukadiri, H., Chollet, P., Moro, F., Dutt, K., Malecaze, F., and Plouet, J. 1995. Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J. Cell. Physiol. 164:385–394.PubMedCrossRefGoogle Scholar
  51. Guo, D., Jia, Q., Song, H. Y., Warren, R. S., and Donner, D. B. 1995. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J. Biol. Chem. 270:6729–6733.PubMedCrossRefGoogle Scholar
  52. Haigh, J. J., Gerber, H. P., Ferrara, N., and Wagner, E. F. 2000. Conditional inactivation of VEGF-A in areas of collagen2al expression results in embryonic lethality in the heterozygous state. Development 127:1445–1453.PubMedGoogle Scholar
  53. Haning, R. J., Strawn, E., and Nolten, W. 1985. Pathophysiology of the ovarian hyper-stimulation syndrome. Obstet. Gynecol. 166:220–224.Google Scholar
  54. Hiratsuka, S., Minowa, O., Kuno, J., Noda, T., and Shibuya, M. 1998. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. USA 95:9349–9354.PubMedCrossRefGoogle Scholar
  55. Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B., and Leung, D. W. 1991. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5:1806–1814.Google Scholar
  56. Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., and Ferrara, N. 1992. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267:26031–26037.PubMedGoogle Scholar
  57. Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Awartz, M., Fukumura, D., Jain, R. K., and Alitalo, K. 1997. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423–1425.PubMedCrossRefGoogle Scholar
  58. Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., and Alitalo, K. 1996. A novel vascular endothelial growth factor, VEGFC, is a ligand for the F1t4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15:290–298.PubMedGoogle Scholar
  59. Kamat, B. R., Brown, L. F., Manseau, E. J., Senger, D. R., and Dvorak, H. F. 1995. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am. J. Pathol. 146:157–165.PubMedGoogle Scholar
  60. Kendall, R. L., and Thomas, K. A. 1993. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. USA 90:10705–10709.PubMedCrossRefGoogle Scholar
  61. Kendall, R. L., Wang, G., and Thomas, K. A. 1996. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem. Biophys. Res. Commun. 226:324–328.Google Scholar
  62. Keyt, B. A., Berleau, L. T., Nguyen, H. V., Chen, H., Heinsohn, H., Vandlen, R., and Ferrara, N. 1996a. The carboxyl-terminal domain (111–165) of vascular endothelial growth factor is critical for its mitogenic potency. J. Biol. Chem. 271:7788–7795.CrossRefGoogle Scholar
  63. Keyt, B. A., Nguyen, H. V., Berleau, L. T., Duarte, C. M., Park, J., Chen, H., and Ferrara, N. 1996b. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J. Biol. Chem. 271:5638–5646.CrossRefGoogle Scholar
  64. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. 1993. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362:841–844.PubMedCrossRefGoogle Scholar
  65. Kitamoto, Y., Tokunaga, H., and Tomita, K. 1997. Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis. J. Clin. Invest. 99:2351–2357.PubMedCrossRefGoogle Scholar
  66. Kobayashi, H., Okada, Y., Asahina, T., Gotoh, J., and Terao, T. 1998. The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome. J. Mol. Endocrinol. 20:363–374.PubMedCrossRefGoogle Scholar
  67. Kuhn, R., Schwenk, F., Aguet, M., and Rajewsky, K. 1995. Inducible gene targeting in mice. Science 269:1427–1429.PubMedCrossRefGoogle Scholar
  68. Landgren, E., Schiller, P., Cao, Y., and Claesson-Welsh, L. 1998. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1. Oncogene 16:359–367.PubMedCrossRefGoogle Scholar
  69. Lee, J., Gray, A., Yuan, J., Luoh, S. M., Avraham, H., and Wood, W. I. 1996. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc. Natl. Acad. Sci. USA 93:1988–1992.PubMedCrossRefGoogle Scholar
  70. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., and Ferrara, N. 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306–1309.PubMedCrossRefGoogle Scholar
  71. Levin, E. R., Rosen, G. F., Cassidenti, D. L., Yee, B., Meldrum, D., Wisot, A., and Pedram, A. 1998. Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome. J. Clin. Invest. 102:1978–1985.PubMedCrossRefGoogle Scholar
  72. Lyttle, D. J., Fraser, K. M., Flemings, S. B., Mercer, A. A., and Robinson, A. J. 1994. Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus. J. Virol. 68:84–92.PubMedGoogle Scholar
  73. Maglione, D., Guerriero, V., Viglietto, G., Ferraro, M. G., Aprelikova, O., Alitalo, K., Del Vecchio, S., Lei, K. J., Chou, J. Y., and Persico, M. G. 1993. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (P1GF), are transcribed from a single gene of chromosome 14. Oncogene 8:925–931.PubMedGoogle Scholar
  74. Mahnke, J. L., Dawood, M. Y., and Huang, J. C. 2000. Vascular endothelial growth factor and interleukin-6 in peritoneal fluid of women with endometriosis. Fertil. Steril. 73:166–170.CrossRefGoogle Scholar
  75. Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegend, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopulos, N., Daly, T. J., Davis, S., Sato, T. N., and Yancopoulos, G. D. 1997. Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis. Science 277:55–60.PubMedCrossRefGoogle Scholar
  76. Matthews, W., Jordan, C. T., Gavin, M., Jenkins, N. A., Copeland, N. G., and Lemischka, I. R. 1991. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc. Natl. Acad. Sci. USA 88:9026–9030.PubMedCrossRefGoogle Scholar
  77. McClure, N., Healy, D. L., Rogers, P. A., Sullivan, J., Beaton, L., Haning, R. V., Connolly, D. T., and Robertson, D. M. 1994. Vascular endothelial growth factor as a capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 344:235–236.PubMedCrossRefGoogle Scholar
  78. McLaren, J., Prentice, A., Charnock-Jones, D. S., Millican, S. A., Muller, K. H., Sharkey, A. M., and Smith, S. K. 1996. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J. Clin. Invest. 98:482–489.PubMedCrossRefGoogle Scholar
  79. Mesiano, S., Ferrara, N., and Jaffe, R. B. 1998. Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization. Am. J. Pathol. 153:1249–1256.PubMedCrossRefGoogle Scholar
  80. Meyer, M., Clauss, M., Lepple-Wienhues, A., Waltenberger, J., Augustin, H. G., Ziche, M., Lanz, C., Buttner, M., Rziha, H. J., and Dehio, C. 1999. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases EMBO J. 18:363–374.Google Scholar
  81. Midy, V., and Plouet, J. 1994. Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem. Biophys. Res. Commun. 199:380–386.Google Scholar
  82. Migdal, M., Huppertz, B., Tessler, S., Comforti, A., Shibuya, M., Reich, R., Baumann, H., and Neufeld, G. 1998. Neuropilin-1 is a placenta growth factor-2 receptor. J. Biol. Chem. 273:22272–22278.PubMedCrossRefGoogle Scholar
  83. Morbidelli, L., Chang, C. H., Douglas, J. G., Granger, H. J., Ledda, F., and Ziche, M. 1996. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am. J. Physiol. 270:H411–H415.PubMedGoogle Scholar
  84. Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13:9–22.PubMedGoogle Scholar
  85. Oberg-Welsh, C., Sandler, S., Andersson, A., and Welsh, M. 1997. Effects of vascular endothelial growth factor on pancreatic duct cell replication and the insulin production of fetal islet-like cell clusters in vitro. Mol. Cell. Endocrinol. 126:125–132.Google Scholar
  86. Ogawa, S., Oku, A., Sawano, A., Yamaguchi, S., Yazaki, Y., and Shibuya, M. 1998. A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. J. Biol. Chem. 273:31273–31282.PubMedCrossRefGoogle Scholar
  87. Ortega, N., Hutchings, H., and Plouet, J. 1999. Signal relays in the VEGF system. Front. Biosci. 4:D141–D152.Google Scholar
  88. Ortega, N., Jonca, F., Vincent, S., Favard, C., Ruchoux, M. M., and Plouet, J. 1997. Systemic activation of the vascular endothelial growth factor receptor KDR/flk-1 selectively triggers endothelial cells with an angiogenic phenotype. Am. J. Pathol. 151:1215–1224.PubMedGoogle Scholar
  89. Pajusola, K., Aprelikova, O., Korhonen, J., Kaipainen, A., Pertovaara, L., Alitalo, R., and Alitalo, K. 1992. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer. Res. 52:5738–5743.Google Scholar
  90. Park, J. E., Chen, H. H., Winer, J., Houck, K. A., and Ferrara, N. 1994. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem. 269:25646–25654.PubMedGoogle Scholar
  91. Park, J. E., Keller, H.-A., and Ferrara, N. 1993. The vascular endothelial growth factor isoforms (VEGF): differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell 4:1317–1326.Google Scholar
  92. Phillips, H. S., Hains, J., Leung, D. W., and Ferrara, N. 1990. Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology 127:965–967.PubMedCrossRefGoogle Scholar
  93. Plouet, J., Schilling, J., and Gospodarowicz, D. 1989. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT20 cells. EMBO J. 8:38013808.Google Scholar
  94. Poltorak, Z., Cohen, T., Sivan, R., Kandelis, Y., Spira, G., Vlodaysky, I., Keshet, E., and Neufeld, G. 1997. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J. Biol. Chem. 272:7151–7158.PubMedCrossRefGoogle Scholar
  95. Poole, A. R. 1991. Cartilage: Molecular Aspects. CRC Press, Boca Raton, FL, pp. 179–211. Ravindranath, N., Little-Ihrig, L., Phillips, H. S., Ferrara, N., and Zeleznik, A. J. 1992. Vas-cular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. Endocrinology 131:254–260.Google Scholar
  96. Risau, W. 1997. Mechanisms of angiogenesis. Nature 386:671–674.PubMedCrossRefGoogle Scholar
  97. Roberts, W. G., and Palade, G. E. 1995. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell Sci. 108:2369–2379.PubMedGoogle Scholar
  98. Roberts, W. G., and Palade, G. E. 1997. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res. 57:765–772.PubMedGoogle Scholar
  99. Ryan, A. M., Eppler, D. B., Hagler, K. E., Bruner, R. H., Thomford, P. J., Hall, R. L., Shopp, G. M., and O’Neill, C. A. 1999. Preclinical safety evaluation of rhuMAbVEGF, an antiangiogenic humanized monoclonal antibody. Toxicol. Pathol. 27:78–86.Google Scholar
  100. Salven, P., Ruotsalainen, T., Mattson, K., and Joensuu, H. 1998. High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer. Int. J. Cancer 79:144–146.PubMedCrossRefGoogle Scholar
  101. Salven, P., Teerenhovi, L., and Joensuu, H. 1997. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin’s lymphoma. Blood 90:3167–3172.PubMedGoogle Scholar
  102. Seetharam, L., Gotoh, N., Maru, Y., Neufeld, G., Yamaguchi, S., and Shibuya, M. A. 1995. Unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 10:135–147.PubMedGoogle Scholar
  103. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., and Dvorak, H. F. 1983. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983–985.PubMedCrossRefGoogle Scholar
  104. Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L., and Schuh, A. C. 1995. Failure of blood-island formation and vasculogenesis in Flk-1deficient mice. Nature 376:62–66.PubMedCrossRefGoogle Scholar
  105. Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H., and Sato, M. 1990. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase (flt) closely related to the fms family. Oncogene 8:519–527.Google Scholar
  106. Shifren, J. L., Tseng, J. F., Zaloudek, C. J., Ryan, I. P., Meng, Y. G., Ferrara, N., Jaffe, R. B., and Taylor, R. N. 1996. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J. Clin. EndocrinoL Metabol. 81:3112–3118.CrossRefGoogle Scholar
  107. Shima, D. T., Kuroki, M., Deutsch, U., Ng, Y. S., Adamis, A. P., and D’Amore, P. A. 1996. The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J. BioL Chem. 271:3877–3883.PubMedCrossRefGoogle Scholar
  108. Shweiki, D., Itin, A., Neufeld, G., Gitay-Goren, H., and Keshet, E. 1993. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally-mediated angiogenesis. J. Clin. Invest. 91:2235–2243.PubMedCrossRefGoogle Scholar
  109. Simon, M., Grone, H. J., Johren, O., Kullmer, J., Plate, K. H., Risau, W., and Fuchs, E. 1995. Expression of vascular endothelial growth factor and its receptors in human renal onto-genesis and in adult kidney. Am. J. Physiol. 268:F240–F250.PubMedGoogle Scholar
  110. Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., and Klagsbrun, M. 1998. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92:735–745.PubMedCrossRefGoogle Scholar
  111. Sondell, M., Lundborg, G., and Kanje, M. 1999. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J. Neurosci. 19:5731–5740.PubMedGoogle Scholar
  112. Sowter, H. M., Corps, A. N., Evans, A. L., Clark, D. E., Charnock-Jones, D. S., and Smith, S. K. 1997. Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors. Lab. Invest. 77:607–614.Google Scholar
  113. Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., and Yancopoulos, G. D. 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171–1180.PubMedCrossRefGoogle Scholar
  114. Takigawa, N., Segawa, Y., Fujimoto, N., Hotta, K., and Eguchi, K. 1998. Elevated vascular endothelial growth factor levels in sera of patients with lung cancer. Anticancer Res. 18:1251–1254.PubMedGoogle Scholar
  115. Terman, B. I., Carrion, M. E., Kovacs, E., Rasmussen, B. A., Eddy, R. L., and Shows, T. B. 1991. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6:1677–1683.PubMedGoogle Scholar
  116. Terman, B. I., Dougher Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., and Böhlen, P. 1992. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187:1579–1586.Google Scholar
  117. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., and Abraham, J. A. 1991. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. BioL Chem. 266:1194711954.Google Scholar
  118. Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., and Werb, Z. 1998. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411–422.PubMedCrossRefGoogle Scholar
  119. Waltenberger, J., Claesson Welsh, L., Siegbahn, A., Shibuya, M., and Heldin, C. H. 1994. Different signal transduction properties of KDR and Fltl, two receptors for vascular endothelial growth factor. J. BioL Chem. 269:26988–26995.PubMedGoogle Scholar
  120. Wiesmann, C., Fuh, G., Christinger, H. W., Eigenbrot, C., Wells, J. A., and de Vos, A. M. 1997. Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell 91:695–704.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Napoleone Ferrara

There are no affiliations available

Personalised recommendations